SLWA

San Luis Wealth Advisors Portfolio holdings

AUM $465M
This Quarter Return
+25.85%
1 Year Return
+11.37%
3 Year Return
+53.44%
5 Year Return
10 Year Return
AUM
$155M
AUM Growth
Cap. Flow
+$155M
Cap. Flow %
100%
Top 10 Hldgs %
38.1%
Holding
122
New
122
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Technology 16.18%
2 Consumer Discretionary 10.55%
3 Energy 5.19%
4 Consumer Staples 5.17%
5 Financials 4.22%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CSQ icon
101
Calamos Strategic Total Return Fund
CSQ
$2.99B
$370K 0.24%
+23,423
New +$370K
ES icon
102
Eversource Energy
ES
$23.8B
$370K 0.24%
+4,275
New +$370K
PSX icon
103
Phillips 66
PSX
$54.1B
$358K 0.23%
+5,121
New +$358K
SYY icon
104
Sysco
SYY
$38.5B
$355K 0.23%
+4,778
New +$355K
HD icon
105
Home Depot
HD
$404B
$346K 0.22%
+1,301
New +$346K
EMR icon
106
Emerson Electric
EMR
$74.3B
$344K 0.22%
+4,285
New +$344K
GD icon
107
General Dynamics
GD
$87.3B
$332K 0.21%
+2,231
New +$332K
MMM icon
108
3M
MMM
$82.8B
$330K 0.21%
+1,886
New +$330K
IGSB icon
109
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$21.5B
$328K 0.21%
+5,948
New +$328K
SPSB icon
110
SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$8.38B
$314K 0.2%
+10,000
New +$314K
PPT
111
Putnam Premier Income Trust
PPT
$353M
$306K 0.2%
+65,811
New +$306K
CL icon
112
Colgate-Palmolive
CL
$67.9B
$293K 0.19%
+3,428
New +$293K
WPC icon
113
W.P. Carey
WPC
$14.7B
$288K 0.19%
+4,086
New +$288K
NVS icon
114
Novartis
NVS
$245B
$274K 0.18%
+2,902
New +$274K
BND icon
115
Vanguard Total Bond Market
BND
$133B
$255K 0.16%
+2,890
New +$255K
PYPL icon
116
PayPal
PYPL
$66.2B
$251K 0.16%
+1,070
New +$251K
BCX icon
117
BlackRock Resources & Commodities Strategy Trust
BCX
$791M
$248K 0.16%
+33,423
New +$248K
V icon
118
Visa
V
$679B
$234K 0.15%
+1,068
New +$234K
GSK icon
119
GSK
GSK
$78.5B
$230K 0.15%
+6,262
New +$230K
USB icon
120
US Bancorp
USB
$76B
$210K 0.14%
+4,515
New +$210K
NLY icon
121
Annaly Capital Management
NLY
$13.5B
$120K 0.08%
+14,165
New +$120K
BMY.RT
122
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$8K 0.01%
+11,070
New +$8K